source
- Pfizer delays patent cliff for blockbuster VyndamaxPfizer is staving off Vyndamax competition for another two years. The drug, also known as tafamidis, is among Pfizer’s top three best-selling medicines and vaccines. Vyndamax is approved for a hear…Endpoints · 3mo ago↗ source
- Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug development“For the first time, FDA regulators will be able to see what’s happening in a clinical trial, looking at endpoints in the cloud as they occur,” writes FDA commissioner.STAT · 3mo ago↗ source
- Hikma and Amarin's generic drug case heads to Supreme Court argumentsWhen the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the entire generic drug industry will be watching. The case could have broad implications o…